Figure 6. Administration of GKD7-L and GKD7-D reduced levels of MMP3 and matrix degradation on cartilage. (A) IHC staining of MMP3, aggrecan, and collagen II expression in a representative cartilage sample from the control, OA, OA+GKD7-L (25 mg/kg), OA+GKD7-L (100 mg/kg), and OA+GKD7-D (100 mg/kg) groups. Quantitative evaluations of cartilage’s MMP3, aggrecan, and collagen II (B–D). Values are presented as the mean ± SD for each group. Scale bar = 100 µm. *p < 0.05 versus controls; #p < 0.05 versus the OA group.